戻る
COSCIENS Biopharma Inc (CSCI)価格
CSCI 株価推移チャート
CSCI 収入
COSCIENS Biopharma Inc
$2.06
0.48%
$0.01
終値： Jan 27, 16:00:00 GMT-5
$2.06
0%
$0
アフターマーケット：Jan 27, 20:00:00 GMT-5
主要データ
前終値
$2.05
始値
$2.72
当日レンジ
$2.06 - $2.72
52週レンジ
$1.96 - $4.6
取引高
200
平均取引高
3.8K
1株当たり利益(TTM)
-6.54
配当利回り
--
時価総額
$6.6M
COSCIENS Biopharma Inc.とは何ですか？
COSCIENS Biopharma Inc. engages in the development and commercialization of diverse pharmaceutical and diagnostic products. The company is headquartered in Toronto, Ontario. The firm is developing and commercializing a diversified portfolio of products for the cosmeceutical, nutraceutical and pharmaceutical markets. The Company’s patented technologies include the Pressurized Gas eXpanded (PGX) technology, which is a technology that generates high-value yields of active ingredients from natural-based resources for use in novel cosmeceutical, nutraceutical and pharmaceutical products. The firm's two products, oat beta glucan and avenanthramides, are found in household-name cosmetic and personal care brands. These products are manufactured from the Company’s proprietary oat extraction manufacturing technology and are known for their well-documented health benefits. Its lead product, macimorelin (Macrilen; Ghryvelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD).